Pharmacologic actions of progestins to inhibit cervical ripening and prevent delivery depend on their properties, the route of administration, and the vehicle

American Journal of Obstetrics and Gynecology

Volumn 202, Issue 5, 2010, Pages 455.e1-455.e9

  Kuon, Ruben J ^a,b   Shi, Shao Qing ^a   Maul, Holger ^b   Sohn, Christof ^b   Balducci, James ^a   Maner, William L ^a   Garfield, Robert E ^a  

^a ST JOSEPH'S HOSPITAL AND MEDICAL CENTER   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

17 alpha hydroxyprogesterone caproate; cervix; preterm labor; progesterone; rat

Indexed keywords

FISH OIL; HYDROXYPROGESTERONE CAPROATE; MIFEPRISTONE; POLYCARBOPHIL; PROGESTERONE; PROMEGESTONE; SESAME SEED OIL;

ARTICLE; CONTROLLED STUDY; DELIVERY; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; FEMALE; FLUORESCENCE ANALYSIS; IN VIVO STUDY; LABOR ONSET; NEWBORN; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUERPERIUM; RAT; TREATMENT DURATION; TREATMENT RESPONSE; UTERINE CERVIX RIPENING;

EID: 77951798541     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2010.03.025     Document Type: Article

References (52)

1. Goldenberg R., Culhane J., Iams J., and Romero R. Epidemiology and causes of preterm birth. Lancet 371 (2008) 75-84
2. Steer P. The epidemiology of preterm labour. BJOG 112 suppl 1 (2005) 1-3
3. Martin J.A., Hamilton B.E., Sutton P.D., et al. Births: Final data for 2006. Natl Vital Stat Rep 57 (2009) 1-104
4. Berkowitz G.S., and Papiernik E. Epidemiology of preterm birth. Epidemiol Rev 15 (1993) 414-443
5. Behrman R., and Butler A. Preterm birth: causes, consequences, and prevention (2007), The National Academies Press, Washington (DC) 398-429
6. Uldbjerg N., Ekman G., Malmström A., Olsson K., and Ulmsten U. Ripening of the human uterine cervix related to changes in collagen, glycosaminoglycans, and collagenolytic activity. Am J Obstet Gynecol 147 (1983) 662-666
7. Rechberger T., Uldbjerg N., and Oxlund H. Connective tissue changes in the cervix during normal pregnancy and pregnancy complicated by cervical incompetence. Obstet Gynecol 71 (1988) 563-567
8. Chwalisz K., Benson M., Scholz P., Daum J., Beier H.M., and Hegele-Hartung C. Cervical ripening with the cytokines IL-8, IL-1β1-beta and TNFα in guinea-pigs. Hum Reprod 9 (1994) 2173-2181
9. Junqueira L.C., Zugaib M., Montes G.S., Toledo O.M., Krisztan R.M., and Shigihara K.M. Morphologic and histochemical evidence for the occurrence of collagenolysis and for the role of neutrophilic polymorphonuclear leukocytes during cervical dilation. Am J Obstet Gynecol 138 (1980) 273-281
10. Osmers R., Rath W., Adelmann-Grill B.C., et al. Origin of cervical collagenase during parturition. Am J Obstet Gynecol 166 (1992) 1455-1460
11. Glassman W., Byam-Smith M., and Garfield R.E. Changes in rat cervical collagen during gestation and after antiprogesterone treatment as measured in vivo with light-induced autofluorescence. Am J Obstet Gynecol 173 (1995) 1550-1556
12. Clark K., Ji H., Feltovich H., Janowski J., Carroll C., and Chien E.K. Mifepristone-induced cervical ripening: structural, biomechanical, and molecular events. Am J Obstet Gynecol 194 (2006) 1391-1398
13. Cheah S.H., Ng K.H., Johgalingam V.T., and Ragavan M. The effects of oestradiol and relaxin on extensibility and collagen organization of the pregnant rat cervix. J Endocrinol 146 (1995) 331-337
14. Ji H., Dailey T.L., Long V., and Chien E.K. Androgen-regulated cervical ripening: a structural, biomechanical, and molecular analysis. Am J Obstet Gynecol 198 (2008) 543.e1-543.e9
15. Shi L., Shi S.Q., Saade G.R., Chwalisz K., and Garfield R.E. Studies of cervical ripening in pregnant rats: effects of various treatments. Mol Hum Reprod 6 (2000) 382-389
16. Maul H., Shi L., Marx S.G., Garfield R.E., and Saade G.R. Local application of platelet-activating factor induces cervical ripening accompanied by infiltration of polymorphonuclear leukocytes in rats. Am J Obstet Gynecol 187 (2002) 829-833
17. Facchinetti F., Paganelli S., Comitini G., Dante G., and Volpe A. Cervical length changes during preterm cervical ripening: effects of 17-alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol 196 (2007) 453.e1-453.e4 discussion 421
18. DeFranco E.A., O'Brien J.M., Adair C.D., et al. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 30 (2007) 697-705
19. Fittkow C.T., Shi S.Q., Bytautiene E., Olson G., Saade G.R., and Garfield R.E. Changes in light-induced fluorescence of cervical collagen in guinea pigs during gestation and after sodium nitroprusside treatment. J Perinat Med 29 (2001) 535-543
20. Johnson J.W., Austin K.L., Jones G.S., Davis G.H., and King T.M. Efficacy of 17alpha-hydroxyprogesterone caproate in the prevention of premature labor. N Engl J Med 293 (1975) 675-680
21. Keirse M.J. Progestogen administration in pregnancy may prevent preterm delivery. BJOG 97 (1990) 149-154
22. Meis P.J., Klebanoff M., Thom E., et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 348 (2003) 2379-2385
23. Da Fonseca E.B., Bittar R.E., Carvalho M.H., and Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 188 (2003) 419-424
24. Keirse M.J. Progesterone and preterm: seventy years of "déjà vu" or "still to be seen"?. Birth 31 (2004) 230-235
25. O'Brien J.M., Adair C.D., Lewis D.F., et al. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 30 (2007) 687-696
26. Da Fonseca E.B., Celik E., Parra M., Singh M., and Nicolaides K.H. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 357 (2007) 462-469
27. Durnwald C.P., Lynch C.D., Walker H., and Iams J.D. The effect of treatment with 17 alpha-hydroxyprogesterone caproate on changes in cervical length over time. Am J Obstet Gynecol 201 (2009) 410.e1-410.e5
28. Garfield R.E., Gasc J.M., and Baulieu E.E. Effects of the antiprogesterone RU 486 on preterm birth in the rat. Am J Obstet Gynecol 157 (1987) 1281-1285
29. Fittkow C.T., Maul H., Olson G., et al. Light-induced fluorescence of the human cervix decreases after prostaglandin application for induction of labor at term. Eur J Obstet Gynecol Reprod Biol 123 (2005) 62-66
30. Shi L., Shi S.Q., Saade G.R., Chwalisz K., and Garfield R.E. Changes in cervical resistance and collagen fluorescence during gestation in rats. J Perinat Med 27 (1999) 188-194
31. O'Brien J.M., Defranco E.A., Adair C.D., et al. Effect of progesterone on cervical shortening in women at risk for preterm birth: secondary analysis from a multinational, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 34 (2009) 653-659
32. Society for Maternal Fetal Medicine Publications Committee. Use of progesterone to reduce preterm birth: ACOG committee opinion no. 419 (replaces no. 291). Obstet Gynecol 112 (2008) 963-965
33. Garfield R.E., Puri C.P., and Csapo A.I. Endocrine, structural, and functional changes in the uterus during premature labor. Am J Obstet Gynecol 142 (1982) 21-27
34. Pepe G.J., and Rothchild I. A comparative study of serum progesterone levels in pregnancy and in various types of pseudopregnancy in the rat. Endocrinology 95 (1974) 275-279
35. Peyron R., Aubény E., Targosz V., et al. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med 328 (1993) 1509-1513
36. Chwalisz K. The use of progesterone antagonists for cervical ripening and as an adjunct to labour and delivery. Hum Reprod 9 suppl 1 (1994) 131-161
37. Zakar T., and Hertelendy F. Progesterone withdrawal: key to parturition. Am J Obstet Gynecol 196 (2007) 289-296
38. Yellon S.M., Ebner C.A., and Elovitz M.A. Medroxyprogesterone acetate modulates remodeling, immune cell census, and nerve fibers in the cervix of a mouse model for inflammation-induced preterm birth. Reprod Sci 16 (2009) 257-264
39. Ruddock N.K., Shi S.Q., Jain S., et al. Progesterone, but not 17-alpha-hydroxyprogesterone caproate, inhibits human myometrial contractions. Am J Obstet Gynecol 199 (2008) 391.e1-391.e7
40. Stjernholm-Vladic Y., Wang H., Stygar D., Ekman G., and Sahlin L. Differential regulation of the progesterone receptor A and B in the human uterine cervix at parturition. Gynecol Endocrinol 18 (2004) 41-46
41. Mesiano S. Myometrial progesterone responsiveness and the control of human parturition. J Soc Gynecol Investig 11 (2004) 193-202
42. Cicinelli E. Intravaginal oestrogen and progestin administration: advantages and disadvantages. Best Pract Res Clin Obstet Gynaecol 22 (2008) 391-405
43. De Ziegler D., Bulletti C., De Monstier B., et al. The first pass uterine effect. Ann N Ann N Y Acad SciY Acad Sci 828 (1997) 291-299
44. Cicinelli E., Cignarelli M., Sabatelli S., et al. Plasma concentrations of progesterone are higher in the uterine artery than in the radial artery after vaginal administration of micronized progesterone in an oil-based solution to postmenopausal women. Fertil Steril 69 (1998) 471-473
45. Levine H., and Watson N. Comparison of the pharmacokinetics of crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women. Fertil Steril 73 (2000) 516-521
46. Richardson J.L., and Illum L. The vaginal route of peptide and protein drug delivery. Adv Drug Deliv Rev 8 (1992) 341-366
47. Cicinelli E., Di Naro E., De Ziegler D., et al. Placement of the vaginal 17b-estradiol tablets in the inner or outer one third of the vagina affects the preferential delivery of 17b-estradiol towards the uterus or peri-urethral areas, thereby modifying efficacy and endometrial safety. Am J Obstet Gynecol 189 (2003) 55-58
48. Schindler A.E., Campagnoli C., Druckmann R., et al. Classification and pharmacology of progestins. Maturitas 61 (2008) 171-180
49. Garfield R.E., Kannan M.S., and Daniel E.E. Gap junction formation in myometrium: control by estrogens, progesterone, and prostaglandins. Am J Physiol 238 (1980) C81-C89
50. Garfield R.E., Saade G., Buhimschi C., et al. Control and assessment of the uterus and cervix during pregnancy and labour. Hum Reprod Update 4 (1998) 673-695
51. Shi S.Q., Maner W.L., Mackay L.B., and Garfield R.E. Identification of term and preterm labor in rats using artificial neural networks on uterine electromyography signals. Am J Obstet Gynecol 198 (2008) 235.e1-235.e4
52. Sexton D.J., O'Reilly M.W., Friel A.M., and Morrison J.J. Functional effects of 17 alpha-hydroxyprogesterone caproate (17P) on human myometrial contractility in vitro. Reprod Biol Endocrinol 2 (2004) 80